Anne Simonsen

Prof. Anne Simonsen


Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2008 in Autophagy
Verified
Journal Article
Closed access
DKDaniel J. Klionsky
Daniel J. Klionsky
HAHagai Abeliovich
Hagai Abeliovich
PAPatrizia Agostinis
Patrizia Agostinis
DADevendra K Agrawal
Devendra K Agrawal
GAGjumrakch Aliev
Gjumrakch Aliev
RDRussell L Deter
Russell L Deter
(2008). Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy: Vol. 4, No. 2, pp. 151-175.

30 August 2021 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
DKDaniel J. Klionsky
Daniel J. Klionsky
GPGiulia Petroni
Giulia Petroni
RARavi K Amaravadi
Ravi K Amaravadi
EBEric H Baehrecke
Eric H Baehrecke
ABAndrea Ballabio
Andrea Ballabio
FPFederico Pietrocola
Federico Pietrocola
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

23 February 2015 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
Lorenzo GalluzziLorenzo Galluzzi
Lorenzo Galluzzi
FPFederico Pietrocola
Federico Pietrocola
José Manuel Bravo San PedroJosé Manuel Bravo San Pedro
José Manuel Bravo San Pedro
RARavi K Amaravadi
Ravi K Amaravadi
EBEric H Baehrecke
Eric H Baehrecke
Guido KroemerGuido Kroemer
Guido Kroemer
Autophagy plays a key role in the maintenance of cellular homeostasis. In healthy cells, such a homeostatic activity constitutes a robust barrier against malignant transformation. Accordingly, many oncoproteins inhibit, and several oncosuppressor proteins promote, autophagy. Moreover, autophagy is required for optimal anticancer immunosurveillance. In neoplastic cells, however, autophagic responses constitute a means to cope with intracellular and environmental stress, thus favoring tumor progression. This implies that at least in some cases, oncogenesis proceeds along with a temporary inhibition of autophagy or a gain of molecular functions that antagonize its oncosuppressive activity. Here, we discuss the differential impact of autophagy on distinct phases of tumorigenesis and the implications of this concept for the use of autophagy modulators in cancer therapy.

30 July 1998 in Nature
Verified
Journal Article
Closed access
PDF file
ASAnne Simonsen
Anne Simonsen
RLRoger Lippe
Roger Lippe
SCSavvas Christoforidis
Savvas Christoforidis
JGJean-Michel Gaullier
Jean-Michel Gaullier
ABAndreas Brech
Andreas Brech
HSHarald Stenmark
Harald Stenmark

16 February 2008 in Autophagy
Verified
Journal Article
Closed access
ASAnne Simonsen
Anne Simonsen
RCRobert C. Cumming
Robert C. Cumming
ABAndreas Brech
Andreas Brech
PIPauline Isakson
Pauline Isakson
DSDavid R. Schubert
David R. Schubert
KFKim D. Finley
Kim D. Finley
Autophagy is involved with the turnover of intracellular components and the management of stress responses. Genetic studies in mice have shown that suppression of neuronal autophagy can lead to the...

5 November 2007 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
MFMaria Filimonenko
Maria Filimonenko
SSSusanne Stuffers
Susanne Stuffers
CRCamilla Raiborg
Camilla Raiborg
AYAi Yamamoto
Ai Yamamoto
LMLene Malerød
Lene Malerød
ASAnne Simonsen
Anne Simonsen
The endosomal sorting complexes required for transport (ESCRTs) are required to sort integral membrane proteins into intralumenal vesicles of the multivesicular body (MVB). Mutations in the ESCRT-III subunit CHMP2B were recently associated with frontotemporal dementia and amyotrophic lateral sclerosis (ALS), neurodegenerative diseases characterized by abnormal ubiquitin-positive protein deposits in affected neurons. We show here that autophagic degradation is inhibited in cells depleted of ESCRT subunits and in cells expressing CHMP2B mutants, leading to accumulation of protein aggregates containing ubiquitinated proteins, p62 and Alfy. Moreover, we find that functional MVBs are required for clearance of TDP-43 (identified as the major ubiquitinated protein in ALS and frontotemporal lobar degeneration with ubiquitin deposits), and of expanded polyglutamine aggregates associated with Huntington's disease. Together, our data indicate that efficient autophagic degradation requires functional MVBs and provide a possible explanation to the observed neurodegenerative phenotype seen in patients with CHMP2B mutations.